Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression

摘要

The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer (NSCLC), based on the use of his levels of BRCA1 expression to predict the outcome of chemotherapy.